Learning Objectives:
- To understand the process of developing a first-in-class drug
- To evaluate the potential of siRNA therapeutics in cancer
- To understand mechanisms of resistance
Session date:
06/24/2024 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
James Brugarolas, MD, PhD